993 related articles for article (PubMed ID: 24907749)
1. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
2. One-pot synthesis of water-soluble superparamagnetic iron oxide nanoparticles and their MRI contrast effects in the mouse brains.
Wang J; Zhang B; Wang L; Wang M; Gao F
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():416-23. PubMed ID: 25579942
[TBL] [Abstract][Full Text] [Related]
3. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Hu F; Jia Q; Li Y; Gao M
Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
[TBL] [Abstract][Full Text] [Related]
4. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
5. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
6. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
8. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.
Hobson NJ; Weng X; Siow B; Veiga C; Ashford M; Thanh NT; Schätzlein AG; Uchegbu IF
Nanomedicine (Lond); 2019 May; 14(9):1135-1152. PubMed ID: 31050589
[No Abstract] [Full Text] [Related]
9. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
[TBL] [Abstract][Full Text] [Related]
10. Effect of PEG molecular weight on stability, T₂ contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs).
Park YC; Smith JB; Pham T; Whitaker RD; Sucato CA; Hamilton JA; Bartolak-Suki E; Wong JY
Colloids Surf B Biointerfaces; 2014 Jul; 119():106-14. PubMed ID: 24877593
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of pseudopolyrotaxanes-coated Superparamagnetic Iron Oxide Nanoparticles as new MRI contrast agent.
Hosseini F; Panahifar A; Adeli M; Amiri H; Lascialfari A; Orsini F; Doschak MR; Mahmoudi M
Colloids Surf B Biointerfaces; 2013 Mar; 103():652-7. PubMed ID: 23199519
[TBL] [Abstract][Full Text] [Related]
13. The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents.
Chen A; Sun J; Liu S; Li L; Peng X; Ma L; Zhang R
Biomater Sci; 2020 Jan; 8(1):379-390. PubMed ID: 31728481
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol.
Ruiz A; Hernández Y; Cabal C; González E; Veintemillas-Verdaguer S; Martínez E; Morales MP
Nanoscale; 2013 Dec; 5(23):11400-8. PubMed ID: 23832394
[TBL] [Abstract][Full Text] [Related]
15. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating.
Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979
[TBL] [Abstract][Full Text] [Related]
16. The labeling of stem cells by superparamagnetic iron oxide nanoparticles modified with PEG/PVP or PEG/PEI.
Yang G; Ma W; Zhang B; Xie Q
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():384-90. PubMed ID: 26952437
[TBL] [Abstract][Full Text] [Related]
17. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
18. Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study.
Yin S; Li Z; Cheng L; Wang C; Liu Y; Chen Q; Gong H; Guo L; Li Y; Liu Z
Nanoscale; 2013 Dec; 5(24):12464-73. PubMed ID: 24165858
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles.
Zolata H; Abbasi Davani F; Afarideh H
Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750
[TBL] [Abstract][Full Text] [Related]
20. Effect of surface coating on the biocompatibility and in vivo MRI detection of iron oxide nanoparticles after intrapulmonary administration.
Al Faraj A; Shaik AP; Shaik AS
Nanotoxicology; 2015; 9(7):825-34. PubMed ID: 26356541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
